[Design of topically resorptive interferon drugs]
- PMID: 8983408
[Design of topically resorptive interferon drugs]
Abstract
The current data on the development and design of topically resorptive interferon drugs are summarized. In many cases it is advisable to use topically resorptive interferon agents which allows them to topically affect a clinical process, to avoid negative sequelae seen when high-dose interferon is unjustifiably systematically given, by reducing its use to a minimum. Interferon is known to be one of the best antiviral agent, besides, it produces marked antimicrobial and antitumor effects. Whether interferon as a component of drugs can be stabilized by axillaries of various chemical nature which act as stabilizers, promoters, and carriers is dealt with. The topically resorptive formulations designed in terms of biopharmaceutical factors are described. The advantages of topically resorptive agents over other drugs are shown and hence they can be widely used in practical medicine.
Similar articles
-
Prolonging the half-life of human interferon-alpha 2 in circulation: Design, preparation, and analysis of (2-sulfo-9-fluorenylmethoxycarbonyl)7- interferon-alpha 2.Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1212-7. doi: 10.1073/pnas.98.3.1212. Proc Natl Acad Sci U S A. 2001. PMID: 11158619 Free PMC article.
-
PEGylated recombinant human interferon-ω as a long-acting antiviral agent: structure, antiviral activity and pharmacokinetics.Antiviral Res. 2014 Aug;108:142-7. doi: 10.1016/j.antiviral.2014.06.003. Epub 2014 Jun 14. Antiviral Res. 2014. PMID: 24936771
-
Interferon-based therapies in COVID-19.Int Immunopharmacol. 2021 Apr;93:107415. doi: 10.1016/j.intimp.2021.107415. Epub 2021 Jan 28. Int Immunopharmacol. 2021. PMID: 33540249 Free PMC article. No abstract available.
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Novel interferons for treatment of hepatitis C virus.Clin Liver Dis. 2009 Aug;13(3):351-63. doi: 10.1016/j.cld.2009.05.004. Clin Liver Dis. 2009. PMID: 19628153 Review.